First catalog of spiders of Egypt (Araneae)

Posted by
  First catalog of spiders of Egypt (Araneae) Abstract This study provides a comprehensive catalog of the spider fauna of Egypt, comprising 389 species assigned to 197 genera and 40 families. For each species, all published locality records are compiled and accompanied by complete bibliographic references. The dataset has been carefully reviewed and critically evaluated in light of the most recent taxonomic and faunistic information. Among the recorded species, 55 (14.13%) are currently known only from Egypt and are thus considered endemic. Based on the World Spider Catalog (2026), 28 species are treated as nomina dubia, 23 species lack confirmed records from Egypt, which is not correct, 10 have to be omitted from the Egyptian list and 8 are species inquirenda. Despite the relatively high number of documented species, the Egyptian araneofauna remains insufficiently explored. Given the country’s ecological diversity and biogeographical position, further research is expected to signi...

Peptides from Animal Venoms: A Promising Frontier in Diabetes Therapy via Multi-Target Mechanisms

Posted by

 


Peptides from Animal Venoms: A Promising Frontier in Diabetes Therapy via Multi-Target Mechanisms

Abstract

Background/Objectives: Bioactive peptides derived from animal venoms, toxins, and secretions demonstrate considerable pharmacological potential for use in the management of diabetes mellitus—a highly prevalent metabolic disorder of substantial global health significance. This integrative review systematically evaluated the current evidence regarding the pharmacological mechanisms underlying the antidiabetic properties of these bioactive peptides. Methods: This study was guided by the research question “What are the mechanisms of action of peptides derived from animal venoms in modulating parameters associated with diabetes?” developed using the PECo framework. A comprehensive literature search was executed across Scopus, PubMed, and Web of Science, focusing on studies from the last five years. Out of 190 identified articles, 17 satisfied the inclusion criteria. Results: Twenty-eight distinct peptides were characterized, exhibiting structural diversity with 7–115 amino acid residues and molecular weights of 900–13,000 Da. These compounds were sourced from venomous taxa including sea anemones, marine snails, spiders, centipedes, scorpions, and snakes. Their antidiabetic mechanisms encompassed glucagon-like peptide-1 (GLP-1) receptor agonism, insulin receptor activation, potassium channel inhibition, glucose transporter type 4 (GLUT4) upregulation, and α-amylase inhibition. Sequence analyses revealed substantial homology among peptides with analogous mechanisms—notably Con-Ins and ILP-Ap04, plus SpTx1 and SsTx-4—suggesting that structural determinants underlie their functional characteristics. Toxicological evaluations of nine peptides demonstrated low-toxicity profiles despite originating from toxic venom, crucial for therapeutic development. Conclusions: These peptides exhibited exceptional pharmacological potency with effective doses in nanogram-to-nanomole per kilogram ranges. Collectively, our findings underscore the therapeutic potential of venom-derived peptides as innovative candidates for use in diabetes management.

de Almeida, J.O.C.S.; Comerma-Steffensen, S.G.; de Souza de Almeida Leite, J.R.; Simonsen, U.; Arcanjo, D.D.R. Peptides from Animal Venoms: A Promising Frontier in Diabetes Therapy via Multi-Target Mechanisms. Pharmaceuticals 2025, 18, 1438. https://doi.org/10.3390/ph18101438